A prospective, open-label, multicenter study to assess the pharmacodynamics and safety of repeated use of 30 mg ulipristal acetate

C Jesam, Leila Cochon, AM Salvatierra, Alistair Williams, N Kapp, D. Levy-Gompel, V Branche

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Early online date4 Jan 2016
Publication statusE-pub ahead of print - 4 Jan 2016

Cite this